Phase I Corporate Sponsor Events
Tuesday, February, 5 │ 5:15 pm – 6:45 pm │Hunters Lounge
Portola Pharmaceuticals Roundtable:
Hosts: Stefan Stanko, Regional Business Manager, Portola Pharmaceuticals; Terry Pellecchia, Thrombosis Area Manager
Title: Portola Pharmaceuticals, a biopharmaceutical company
Portola Pharmaceuticals is a biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics that could significantly advance the fields of thrombosis and other hematologic diseases. The company’s two FDA-approved medicines are Bevyxxa® (betrixaban) and Andexxa® [coagulation factor Xa (recombinant), inactivated-zhzo. The company also is advancing cerdulatinib, a Syk/JAK inhibitor for hematologic cancers.
Wednesday, February 6 │ 5:15 pm – 6:45 pm │Hunters Lounge
Hosts: John Walsh, Area Vice President of Clinical, Vapotherm; Adam Nelsen, Area Vice President West, Vapotherm
Title: Don’t be Afraid of Pediatric Strategies for Pediatric Patients Entering the Emergency Department in Respiratory Distress
Come challenge John Walsh to a game of Jenga while he answers your questions on the application of mask-free NIV for spontaneously breathing pediatric patients entering the Emergency Department in respiratory distress. John began as Field Clinical Educator with Vapotherm in 2001. He was one of the early adopters of the technology and the author of the first case study of its use in the Emergency Department.
Complimentary Dinner and Educational Presentations
Portola Pharmaceuticals: Tuesday, February 5 │ 6:45 pm – 8:15 pm │ Park West Ballroom E
Title: Reversal of Specific Novel Oral Anticoagulants in Patients Experiencing Life-threatening Bleeds: Review of Clinical Evidence and Practical Recommendations for Patient Management
Presenter: Robert B. Takla, MD, MBA, FACEP, Medical Director, Emergency Medicine, St. John Hospital and Medical Center, St. John Providence Health System, Wayne State University School of Medicine, Detroit, Michigan
Pick up a dinner ticket at the EDDA registration table during a break. Seating is limited and tickets are offered on a first-come, first-served basis.
Vapotherm: Wednesday, February 6 │ 6:45 pm – 8:15 pm │ Park West Ballroom F
Title: No mask, No problem. Mask-Free NIV for the Spontaneously Breathing Patient
Dr. Kirk Hinkley will discuss current research and his clinical practice experience using High Velocity Nasal Insufflation (HVNI), the first mask-free noninvasive ventilation solution for patients in respiratory distress in the Emergency Department.
Presenter: Kirk Hinkley, MD, Medical Director of Commonwealth Health EMS and Commonwealth One Air Ambulance; Emergency Physician at Cayuga Medical Center in Ithaca, New York
Pick up a dinner ticket at the EDDA registration table during a break, even if you pre-registered online. Seating is limited and tickets are offered on a first-come, first-served basis.
ACEP Directors Academy delivers at the highest level consistently because the passion of the faculty comes through every encounter. It will help anyone be a better EP or EP Director.